Date: Wednesday 13 November 2019
Time: 09:00 - 17:00
Venue: Royal Marsden Education and Conference Centre, London
After the great success of the meetings in 2018 and due to popular demand, we are organising another immunotherapy meeting.
Immune checkpoint inhibitors represent the dawn of a new era in systemic cancer therapy and it is clear that immunotherapy agents will play an increasing role in cancer care over the coming years. This event will provide an overview of cancer immunotherapy, with a focus on the recognition and management of immune-mediated toxicities.
The meeting will have a strong clinical emphasis, aimed at providing delegates with practical guidance that can be utilised in daily practice. We have expanded the programme to include survivorship and palliative care support.
This meeting will be of value to healthcare professionals involved in the delivery of cancer care including doctors, nurses, pharmacists and physician associates working in oncology, acute medicine, emergency medicine, medical specialities and general practice.
The programme is available here.
For further information and to register your place please visit the conference website.